Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$5.60 USD
-0.43 (-7.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $5.61 +0.01 (0.18%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 318 | 363 | 445 | 271 | 228 |
Receivables | 60 | 48 | 49 | 48 | 28 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 15 | 16 | 15 | 11 | 8 |
Total Current Assets | 393 | 428 | 508 | 330 | 264 |
Net Property & Equipment | 26 | 26 | 23 | 13 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 264 | 278 | 275 | 207 | 29 |
Deposits & Other Assets | 5 | 4 | 5 | 4 | 1 |
Total Assets | 702 | 752 | 832 | 578 | 302 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 4 | 5 | 5 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 23 | 20 | 24 | 17 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 56 | 55 | 61 | 64 | 33 |
Total Current Liabilities | 89 | 83 | 93 | 88 | 48 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 2 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 228 | 227 | 181 | 169 | 48 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 15 | 19 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 335 | 327 | 310 | 302 | 102 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,484 | 1,425 | 0 | 0 | 0 |
Capital Surplus | 0 | 0 | 1,401 | 1,002 | 811 |
Retained Earnings | -1,117 | -999 | -879 | -726 | -611 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 367 | 425 | 522 | 276 | 201 |
Total Liabilities & Shareholder's Equity | 702 | 752 | 832 | 578 | 302 |
Total Common Equity | 367 | 425 | 522 | 276 | 201 |
Shares Outstanding | 57.50 | 54.70 | 52.00 | 42.50 | 36.50 |
Book Value Per Share | 6.38 | 7.77 | 10.04 | 6.50 | 5.50 |
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 318 | 348 | 344 | 357 |
Receivables | NA | 60 | 46 | 52 | 62 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 15 | 15 | 15 | 16 |
Total Current Assets | NA | 393 | 408 | 411 | 435 |
Net Property & Equipment | NA | 26 | 26 | 26 | 26 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 264 | 258 | 265 | 270 |
Deposits & Other Assets | NA | 5 | 5 | 5 | 5 |
Total Assets | NA | 702 | 713 | 723 | 752 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 7 | 6 | 8 | 9 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 23 | 21 | 16 | 24 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 56 | 53 | 60 | 66 |
Total Current Liabilities | NA | 89 | 84 | 87 | 103 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 228 | 228 | 227 | 227 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 335 | 331 | 333 | 347 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1,484 | 1,469 | 1,455 | 1,438 |
Capital Surplus | NA | 0 | 0 | 0 | 0 |
Retained Earnings | NA | -1,117 | -1,087 | -1,065 | -1,032 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 367 | 382 | 390 | 405 |
Total Liabilities & Shareholder's Equity | NA | 702 | 713 | 723 | 752 |
Total Common Equity | 0 | 367 | 382 | 390 | 405 |
Shares Outstanding | 58.50 | 57.50 | 56.90 | 56.20 | 56.20 |
Book Value Per Share | 0.00 | 6.38 | 6.72 | 6.94 | 7.21 |